Clinical trial No longer in our active list Interventional Ages 18 and up

Identifying factors affecting upper limb function after breast cancer treatment

Official title: Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment: Longitudinal Cohort Study

Run by KU Leuven · NCT05371847 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at what might be causing ongoing arm problems in breast cancer survivors after treatment to help improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorKU Leuven
Academic / other
Locations1 site (Leuven)
Trial IDNCT05371847 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include breast cancer patients scheduled for surgery and those receiving adjuvant radiotherapy.

Probably not a fit

Patients with widespread metastases or those who have undergone previous breast surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify prognostic variables that contribute to persistent upper limb dysfunctions in breast cancer survivors following treatment. It focuses on assessing upper limb function in patients who have undergone surgery and adjuvant radiotherapy for breast cancer. By understanding these factors, the study seeks to improve the quality of life for breast cancer survivors by addressing barriers to physical activity caused by upper limb dysfunction. The methodology includes assessments and retests to evaluate upper limb function over time.

Why it matters

Potential benefit: If successful, this study could lead to improved interventions that enhance upper limb function and overall quality of life for breast cancer survivors.

How similar studies have gone: Other studies have shown success in identifying factors affecting quality of life in breast cancer survivors, suggesting that this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for breast cancer patients

* Patients scheduled for surgery (mastectomy or breast conserving surgery; in combination with axillary lymph node dissection or sentinel node biopsy) for unilateral primary breast cancer or patients with oligometastatic breast cancer.
* Patients who receive adjuvant radiotherapy .
* Patients with a cognitive and language functioning enabling coherent Dutch communication between the examiner and the participant
* Patients who can comply with the protocol at baseline assessment and willing to provide written informed consent

Inclusion criteria healthy volunteers

* Healthy women and men(quickDASH\<15) age- and gender-matched with a breast cancer patient from the main study
* Volunteers who can comply with the protocol at baseline assessment and willing to provide written informed consent

Exclusion Criteria breast cancer patients

* BCS with widespread distance metastases, previous breast surgery, or planned bilateral surgery
* And/or with a diagnosis of a neurological or rheumatological condition, diabetes,
* And/or BCS who are not available the entire duration of the study

Exclusion Criteria healthy volunteers

* History of breast cancer
* Patients with a diagnosis of neurological or rheumatological condition, diabetes

Where it's running

  • Universitair Ziekenhuis Leuven
    Leuven, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.